Vizient examines growing disease prevalence, technical innovation in A-Fib detection, treatment in latest Medical Device Tech Watch

SpendMend receives expanded contract agreement with Vizient, Inc.

September 1, 2021  –  Vizient, Inc. (Irving, TX) released a report examining the growing prevalence of heart rhythm disorders and new technology to monitor and treat them.

The latest edition of Vizient’s Medical Device Tech Watch offers current and future treatment options for these disorders as well as best practices for interventional procedural areas in cardiology.

The report includes articles with in-depth insights on wearable cardiac devices, best-in-class interventional suites and the latest computer assisted spine surgery technologies:

The articles in this quarter’s publication are:

  • “Increasing disease prevalence and technical innovation drives advancements in atrial fibrillation detection and treatment”
  • “Efficiency gained through best practices for interventional procedural areas”
  • “Navigating the computer assisted spine surgery landscape”

“As top organizations seek to differentiate their service lines, they look to innovative treatment approaches,” said Pam Burton, associate principal, physician preference items consulting for Vizient. “As a services-led, technology enabled resource for the complex process of managing cardiology and orthopedic service lines, we aim to align stakeholders—from all sides—to advance standards of care while reducing inefficiencies and costs.”

Learn More

safe online pharmacy for viagra cheap kamagra oral jelly online